Piper Sandler analyst David Westenberg reiterated an Overweight rating and $130.00 price target on GeneDx (NASDAQ: WGS).The analyst commented: "Sequencing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE